Evaluation of severe neutropenia and diarrhea in Asian cancer patients receiving UGT1A1 genotype-guided irinotecan dosing.

被引：0
|
作者：
Sutiman, Natalia
Ramasamy, Saminathan
Ng, Chau Hsien Matthew
Choo, SuPin
Wenrui, Rachel Lim
Ling, Clarinda Chua Wei
Kuang, John Chia Whay
Tan, Iain B.
Chowbay, Balram
机构：
[1] SingHlth Clin Pharmacol, Singapore, Singapore
[2] Natl Canc Ctr, Div Med Sci, Clin Pharmacol Lab, Singapore, Singapore
[3] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13572
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters
    Ichikawa, Wataru
    Araki, Kazuhiro
    Fujita, Ken-Ichi
    Yamamoto, Wataru
    Endo, Hisashi
    Nagashima, Fumio
    Tanaka, Ryuhei
    Miya, Toshimichi
    Kodama, Keiji
    Sunakawa, Yu
    Narabayashi, Masaru
    Ando, Yuichi
    Akiyama, Yuko
    Kawara, Kaori
    Sasaki, Yasutsuna
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
  • [32] A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.
    Sharma, Manish
    Catenacci, Daniel V. T.
    Karrison, Theodore
    Ganjoo, Anubha
    Allen, Kenisha
    Suh, Grace K.
    Phillips, Brooke Elizabeth
    Marsh, Robert de Wilton
    Kozloff, Mark
    Polite, Blase N.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Clinical Observations on Associations Between the UGT1A1 Genotype and Severe Toxicity of Irinotecan
    Lu, Yan-Yan
    Huang, Xin-En
    Wu, Xue-Yan
    Cao, Jie
    Liu, Jin
    Wang, Lin
    Xiang, Jin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 3335 - 3341
  • [34] Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1☆28 and/or UGT1A1☆6 polymorphisms
    Satoh, Taroh
    Ura, Takashi
    Yamada, Yasuhide
    Yamazaki, Kentaro
    Tsujinaka, Toshimasa
    Munakata, Masaki
    Nishina, Tomohiro
    Okamura, Shu
    Esaki, Taito
    Sasaki, Yasutsuna
    Koizumi, Wasaburo
    Kakeji, Yoshihiro
    Ishizuka, Naoki
    Hyodo, Ichinosuke
    Sakata, Yuh
    CANCER SCIENCE, 2011, 102 (10) : 1868 - 1873
  • [35] UGT1A1☆6 AND UGT1A1☆28 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE LEUKOPENIA IN JAPANESE PATIENTS WITH LUNG CANCER
    Fukuda, Minoru
    Okumura, Manabu
    Hisatomi, Keiko
    Suyama, Naofumi
    Iwakiri, Tomomi
    Takagi, Akinori
    Nakamura, Yoichi
    Arimori, Kazuhiko
    Kohno, Shigeru
    RESPIROLOGY, 2010, 15 : 37 - 37
  • [36] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters -: Reply
    Hoskins, Janelle M.
    McLeod, Howard L.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
  • [37] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    Jada, Srinivasa Rao
    Lim, Robert
    Wong, Chiung Ing
    Shu, Xiaochen
    Lee, Soo Chin
    Zhou, Qingyu
    Goh, Boon Cher
    Chowbay, Balram
    CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
  • [38] UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan
    Stewart, Clinton F.
    Panetta, John C.
    O'Shaughnessy, Melinda A.
    Throm, Stacy L.
    Fraga, Charles H.
    Owens, Thandranese
    Liu, Tiebin
    Billups, Catherine
    Rodriguez-Galindo, Carlos
    Gajjar, Amar
    Furman, Wayne L.
    McGregor, Lisa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2594 - 2600
  • [39] Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?
    Daniel, F.
    Belluomini, L.
    Lancia, F.
    Martella, L.
    Toma, I.
    Moretti, A.
    Banno, E.
    Carandina, I.
    Marzola, M.
    Fabbri, M.
    Frassoldati, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] Genotype-driven dosing of irinotecan and adverse events in patients receiving irinotecan with UGT1A1gene variants.
    Baldeo, Candice
    Hughes, Caren
    Kasi, Pashtoon Murtaza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345